Joseph Sasadeusz

Very late-onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation

Sadid F Khan, Michelle K Yong, Monica A Slavin, Peter Hughes, Joseph Sasadeusz

Journal article  |  2020  |  Transplant Infectious Disease

Cytomegalovirus (CMV) infection is a significant cause of morbidity and mortality after solid organ transplantation. There has bee..

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

Jennifer Audsley, Anchalee Avihingsanon, Margaret Littlejohn, Scott Bowden, Gail Matthews, Christopher K Fairley, Sharon R Lewin, Joe Sasadeusz

Journal article  |  2020  |  Journal of acquired immune deficiency syndromes (1999)

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is effective in suppressing HIV and hepatitis B virus (HBV) replication in HIV-HBV..

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Justin T Denholm, Joshua Davis, David Paterson, Jason Roberts, Susan Morpeth, Thomas Snelling, Dominica Zentner, Megan Rees, Matthew O'Sullivan, David Price, Asha Bowen, Steven YC Tong

Journal article  |  2020  |  Trials

OBJECTIVES: To determine if lopinavir/ritonavir +/- hydroxychloroquine will reduce the proportion of participants who survive with..

Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study

Emma Foster, Michael J Malloy, Vilija G Jokubaitis, C David H Wrede, Helmut Butzkueven, Joe Sasadeusz, Sharon Van Doornum, Finlay Macrae, Gary Unglik, Julia ML Brotherton, Anneke van der Walt

Journal article  |  2020  |  PLoS One

BACKGROUND: Autoimmune conditions (AICs) and/or their treatment may alter risk of human papilloma virus (HPV) infection and female..

Review article: prevention, diagnosis and management of COVID-19 in the IBD patient

Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, Doug Johnson, Zaid Ardalan, Neel Heerasing, Mayur Garg, Sian Campbell, Joe Sasadeusz, Finlay A Macrae, Siew C Ng, David T Rubin, Britt Christensen

Journal article  |  2020  |  Alimentary Pharmacology & Therapeutics

BACKGROUND: The current COVID-19 pandemic, caused by SARS-CoV-2, has emerged as a public health emergency. All nations are serious..

Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era

Thomas R Schulz, Kudzai Kanhutu, Joseph Sasadeusz, Sally Watkinson, Beverley-Ann Biggs

Journal article  |  2020  |  Journal of Telemedicine and Telecare

Introduction One-third of the Australian population lives outside major cities and this group has worse health outcomes. Telehealt..

The QuantiFERON Monitor (R) assay is predictive of infection post allogeneic hematopoietic cell transplantation

Abby P Douglas, Lijia Yu, Vijaya Sundararajan, Jeff Szer, David Ritchie, Monica A Slavin, Joe Sasadeusz, Kumar Visvanathan

Journal article  |  2020  |  Transplant Infectious Disease

INTRODUCTION: Following allogeneic hematopoietic stem cell transplantation (alloHCT), excessive immunosuppression can be complicat..

Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis

Luxi Lal, Kathleen Ryan, Iris Yi Liu, Brian Price, Timmy Lockwood, Ivette Aguirre, Peter Slobodian, Ada Lam, Manoj Vassan, Kie Lim, John Silverii, Joseph Tesoriero, Johnny Phu, Wan Lim, Bharathy Naidoo, Nick Russell, Matthew Rundle, Rowan Sewell, Craig Cooper, Alexander Hardman, et al.

Journal article  |  2019  |  Frontiers in Pharmacology

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Other Populations and Newer Agents

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Because of the relatively high prevalence of both hepatitis B infection and various forms of autoimmune inflammatory diseases trea..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Introduction and Immunology

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Current recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occ..